Highlights of the Targeted Remediation Trial
Several key findings emerged from this randomized clinical trial (RCT) regarding the remediation of the ipsilesional limb in chronic stroke survivors:
1. Targeted ipsilesional training resulted in a statistically significant 12% reduction in time to complete the Jebsen-Taylor Hand Function Test (JTHFT).
2. Improvements in motor performance were not merely transient; they were sustained at both the 3-week and 6-month post-treatment follow-up assessments.
3. The study specifically addressed patients with severe contralesional impairment (Fugl-Meyer score ≤28), for whom the ipsilesional limb is the primary driver of daily functional independence.
4. While motor performance improved, no significant changes were observed in general functional independence (Barthel Index) or contralesional impairment severity, suggesting the intervention is specific to the treated limb.
